Halpert M, Burns B, Rosario S, Withers H, Trivedi A, Hofferek C
FASEB J. 2024; 38(10):e23644.
PMID: 38738472
PMC: 11155525.
DOI: 10.1096/fj.202302675R.
Poirier A, Tremblay M
Cancer Immunol Immunother. 2022; 72(6):1343-1353.
PMID: 36441193
PMC: 10992185.
DOI: 10.1007/s00262-022-03333-y.
Huff A, Jaffee E, Zaidi N
J Clin Invest. 2022; 132(6).
PMID: 35289317
PMC: 8920340.
DOI: 10.1172/JCI156211.
Wabitsch S, McCallen J, Ma C, Greten T
STAR Protoc. 2021; 2(2):100517.
PMID: 34013212
PMC: 8113974.
DOI: 10.1016/j.xpro.2021.100517.
Zhao L, Jiang M, Bai X, Cao D, Wu X, Zhang J
Neurosci Bull. 2020; 37(4):550-562.
PMID: 33355900
PMC: 8055805.
DOI: 10.1007/s12264-020-00621-4.
Escape from X chromosome inactivation and female bias of autoimmune diseases.
Mousavi M, Mahmoudi M, Ghotloo S
Mol Med. 2020; 26(1):127.
PMID: 33297945
PMC: 7727198.
DOI: 10.1186/s10020-020-00256-1.
MHC class I and II peptide homology regulates the cellular immune response.
Halpert M, Konduri V, Liang D, Vazquez-Perez J, Hofferek C, Weldon S
FASEB J. 2020; 34(6):8082-8101.
PMID: 32298026
PMC: 7493300.
DOI: 10.1096/fj.201903002R.
Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial.
Lichtenegger F, Schnorfeil F, Rothe M, Deiser K, Altmann T, Bucklein V
Clin Transl Immunology. 2020; 9(3):e1117.
PMID: 32153780
PMC: 7053229.
DOI: 10.1002/cti2.1117.
Toll-Like Receptor-Mediated Activation of CD39 Internalization in BMDCs Leads to Extracellular ATP Accumulation and Facilitates P2X7 Receptor Activation.
Zhao R, Qiao J, Zhang X, Zhao Y, Meng X, Sun D
Front Immunol. 2019; 10:2524.
PMID: 31736956
PMC: 6834529.
DOI: 10.3389/fimmu.2019.02524.
Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists.
Macedo A, Novis C, Bosque A
Front Immunol. 2019; 10:2450.
PMID: 31681325
PMC: 6804373.
DOI: 10.3389/fimmu.2019.02450.
TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells.
Nouri-Shirazi M, Tamjidi S, Nourishirazi E, Guinet E
Immunol Lett. 2017; 193:58-66.
PMID: 29103998
PMC: 5744900.
DOI: 10.1016/j.imlet.2017.10.015.
Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide-MHC Complexes for T-Cell Receptor Immunotherapy.
Lorenz F, Ellinger C, Kieback E, Wilde S, Lietz M, Schendel D
Hum Gene Ther. 2017; 28(12):1158-1168.
PMID: 28950731
PMC: 5737719.
DOI: 10.1089/hum.2017.122.
Recent developments in immunotherapy of acute myeloid leukemia.
Lichtenegger F, Krupka C, Haubner S, Kohnke T, Subklewe M
J Hematol Oncol. 2017; 10(1):142.
PMID: 28743264
PMC: 5526264.
DOI: 10.1186/s13045-017-0505-0.
TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host Disease.
Lee Y, Kang M, Choi E
Immune Netw. 2017; 17(3):144-151.
PMID: 28680375
PMC: 5484644.
DOI: 10.4110/in.2017.17.3.144.
Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell Maturation.
Sittig S, de Vries I, Schreibelt G
Biomedicines. 2017; 3(4):282-303.
PMID: 28536413
PMC: 5344227.
DOI: 10.3390/biomedicines3040282.
Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells.
Kyte J, Aamdal S, Dueland S, Saeboe-Larsen S, Inderberg E, Madsbu U
Oncoimmunology. 2016; 5(11):e1232237.
PMID: 27999747
PMC: 5139630.
DOI: 10.1080/2162402X.2016.1232237.
Strategies for designing synthetic immune agonists.
Wu T
Immunology. 2016; 148(4):315-25.
PMID: 27213842
PMC: 4948037.
DOI: 10.1111/imm.12622.
Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity.
Dietsch G, Lu H, Yang Y, Morishima C, Chow L, Disis M
PLoS One. 2016; 11(2):e0148764.
PMID: 26928328
PMC: 4771163.
DOI: 10.1371/journal.pone.0148764.
Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy.
Mikyskova R, Stepanek I, Indrova M, Bieblova J, Simova J, Truxova I
Int J Oncol. 2016; 48(3):953-64.
PMID: 26718011
PMC: 4750542.
DOI: 10.3892/ijo.2015.3314.
Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection.
Sachdeva M, Chawla Y, Arora S
World J Hepatol. 2015; 7(19):2202-8.
PMID: 26380045
PMC: 4561774.
DOI: 10.4254/wjh.v7.i19.2202.